Prof. Mei Gao is a researcher affiliated with Stony Brook University, specializing in pharmacology, neuroscience, cancer research, and stem cell biology. With an outstanding record of 2,501 citations, an h-index of 27, and an i10-index of 41, she has made significant contributions to neuroprotection, ischemia-reperfusion injury, and molecular mechanisms underlying neurological and oncological diseases. Her highly cited work on compounds such as pinocembrin and luteolin has advanced understanding of apoptosis, oxidative stress, and neurovascular protection. Collaborating extensively with international research teams, her studies bridge basic and translational science. Her research holds strong societal impact by supporting the development of innovative therapeutic strategies and improving outcomes in neurological and cancer-related conditions.
